KK
DGX icon

KLP Kapitalforvaltning’s Quest Diagnostics DGX Stock Holding History

KLP Kapitalforvaltning’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.2M Buy
43,403
+4,000
+10% +$785K 0.03% 410
2026
Q1 		$7.72M Hold
39,403
– – 0.03% 408
2025
Q4 		$6.84M Buy
39,403
+300
+0.8% +$54.6K 0.03% 440
2025
Q3 		$7.45M Hold
39,103
– – 0.03% 422
2025
Q2 		$7.02M Sell
39,103
-1,200
-3% -$208K 0.03% 420
2025
Q1 		$6.82M Buy
40,303
+3,800
+10% +$624K 0.03% 409
2024
Q4 		$5.51M Buy
+36,503
New +$5.68M 0.03% 467

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

KLP Kapitalforvaltning's DGX Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Quest Diagnostics (DGX) stake by 10% in Q2 2026, buying an estimated $785K and bringing the position to 43,403 shares worth $9.2M. The position accounts for 0.03% of the portfolio, ranked #410.

KLP Kapitalforvaltning first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • KLP Kapitalforvaltning held 43,403 shares of Quest Diagnostics worth $9.2M as of Q2 2026.
  • KLP Kapitalforvaltning bought 4,000 Quest Diagnostics shares in Q2 2026, an estimated $785K.
  • Quest Diagnostics made up 0.03% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #410 holding.
  • KLP Kapitalforvaltning first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.